Working in partnership with industry to bring health benefits to the people of the South West and beyond
Developing commercial partnerships in health and medicine means that we can bring medical technologies out of the lab and into treatment centres.
We’re using experimental medicine and translational research to strengthen our research, improve medical technologies and devices, evaluate and develop new biomarkers and find new drugs and develop new treatments which can benefit our South West communities. We’re actively engaging people in research like clinical trials to help make sure that our communities’ healthcare needs are understood, represented and met.
We use innovative ways of working such as Entrepreneurs-in-Residence, Innovation Scouts and Professors in Practice, inspiring and engaging colleagues to draw on their expertise and networks as we develop a team of clinical and biomedical researchers focused on benefits for patients through deepening relationships with industry.
We have access to a wide range of cutting-edge pharmaceutical trials and digital biomarkers and extensive industry links including Roche, DECODE, CYTOX, Biogen and Alkermes Abbvie, Life Molecular Imaging and Eli Lilly as well as Novo Nordisk and Astra Zeneca. We are expanding our programme of clinical trials and are keen to collaborate with a range of health innovation partners and to hear from potential new partners to bring breakthroughs along the research pipeline towards implementation.
Read a Q&A with Professor Seb Brown
Working in partnership with industry
Explore advice and resources to help academics interested in working with industry on our Training Pages.
Find out more
Working across our partnership between the Royal Devon and the University of Exeter, we’re supporting colleagues to develop spinout companies, using experimental medicine and translational research, to develop new technologies and treatments. Our partnership and existing links to industry means that we have access to a wide range of cutting-edge pharmaceutical trials and digital biomarkers.
We can offer a range of services to foster deepening links with industry and add value to device, drug, and biomarker development.
Get in touch with us or use our enquiry form if you’d like more information.
We use cookies to give you the best experience of our website. By browsing you agree to our use of cookies.